208 related articles for article (PubMed ID: 36991492)
1. CRISPR screens identify gene targets at breast cancer risk loci.
Tuano NK; Beesley J; Manning M; Shi W; Perlaza-Jimenez L; Malaver-Ortega LF; Paynter JM; Black D; Civitarese A; McCue K; Hatzipantelis A; Hillman K; Kaufmann S; Sivakumaran H; Polo JM; Reddel RR; Band V; French JD; Edwards SL; Powell DR; Chenevix-Trench G; Rosenbluh J
Genome Biol; 2023 Mar; 24(1):59. PubMed ID: 36991492
[TBL] [Abstract][Full Text] [Related]
2. Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens.
Morris JA; Caragine C; Daniloski Z; Domingo J; Barry T; Lu L; Davis K; Ziosi M; Glinos DA; Hao S; Mimitou EP; Smibert P; Roeder K; Katsevich E; Lappalainen T; Sanjana NE
Science; 2023 May; 380(6646):eadh7699. PubMed ID: 37141313
[TBL] [Abstract][Full Text] [Related]
3. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
Yim S; Hwang W; Han N; Lee D
Front Immunol; 2022; 13():884561. PubMed ID: 35651625
[TBL] [Abstract][Full Text] [Related]
4. Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells.
Wünnemann F; Fotsing Tadjo T; Beaudoin M; Lalonde S; Lo KS; Kleinstiver BP; Lettre G
PLoS Genet; 2023 Mar; 19(3):e1010680. PubMed ID: 36928188
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.
Wang L; Bitar M; Lu X; Jacquelin S; Nair S; Sivakumaran H; Hillman KM; Kaufmann S; Ziegman R; Casciello F; Gowda H; Rosenbluh J; Edwards SL; French JD
Mol Cancer; 2024 May; 23(1):101. PubMed ID: 38745269
[TBL] [Abstract][Full Text] [Related]
6. Identification of breast cancer associated variants that modulate transcription factor binding.
Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
[TBL] [Abstract][Full Text] [Related]
7. Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens.
Alda-Catalinas C; Ibarra-Soria X; Flouri C; Gordillo JE; Cousminer D; Hutchinson A; Sun B; Pembroke W; Ullrich S; Krejci A; Cortes A; Acevedo A; Malla S; Fishwick C; Drewes G; Rapiteanu R
Genome Biol; 2024 Feb; 25(1):42. PubMed ID: 38308274
[TBL] [Abstract][Full Text] [Related]
8. H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Giambartolomei C; Seo JH; Schwarz T; Freund MK; Johnson RD; Spisak S; Baca SC; Gusev A; Mancuso N; Pasaniuc B; Freedman ML
Am J Hum Genet; 2021 Dec; 108(12):2284-2300. PubMed ID: 34822763
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Shifrut E; Carnevale J; Tobin V; Roth TL; Woo JM; Bui CT; Li PJ; Diolaiti ME; Ashworth A; Marson A
Cell; 2018 Dec; 175(7):1958-1971.e15. PubMed ID: 30449619
[TBL] [Abstract][Full Text] [Related]
10. Translating non-coding genetic associations into a better understanding of immune-mediated disease.
Stankey CT; Lee JC
Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36897113
[TBL] [Abstract][Full Text] [Related]
11. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops.
Guo Y; Perez AA; Hazelett DJ; Coetzee GA; Rhie SK; Farnham PJ
Genome Biol; 2018 Oct; 19(1):160. PubMed ID: 30296942
[TBL] [Abstract][Full Text] [Related]
13. FORGEdb: a tool for identifying candidate functional variants and uncovering target genes and mechanisms for complex diseases.
Breeze CE; Haugen E; Gutierrez-Arcelus M; Yao X; Teschendorff A; Beck S; Dunham I; Stamatoyannopoulos J; Franceschini N; Machiela MJ; Berndt SI
Genome Biol; 2024 Jan; 25(1):3. PubMed ID: 38167104
[TBL] [Abstract][Full Text] [Related]
14. From candidate gene studies to GWAS and post-GWAS analyses in breast cancer.
Fachal L; Dunning AM
Curr Opin Genet Dev; 2015 Feb; 30():32-41. PubMed ID: 25727315
[TBL] [Abstract][Full Text] [Related]
15. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
[TBL] [Abstract][Full Text] [Related]
16. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
Gao G; Pierce BL; Olopade OI; Im HK; Huo D
PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
[TBL] [Abstract][Full Text] [Related]
18. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
Chen CY; Chang IS; Hsiung CA; Wasserman WW
BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR Platform for Targeted In Vivo Screens.
Maranda V; Zhang Y; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
Methods Mol Biol; 2023; 2614():397-409. PubMed ID: 36587138
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection.
Kim HS; Lee K; Bae S; Park J; Lee CK; Kim M; Kim E; Kim M; Kim S; Kim C; Kim JS
J Biol Chem; 2017 Jun; 292(25):10664-10671. PubMed ID: 28446605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
